Is Symtuza a single-tablet regimen for HIV?

Yes—Symtuza is a single-tablet regimen for HIV

Symtuza is an antiretroviral treatment packaged as one pill taken once daily. It combines multiple HIV medicines into a single tablet, making it a single-tablet regimen rather than a multi-pill combination.

What’s inside Symtuza (and why that matters for “single-tablet”)

Symtuza’s “single-tablet regimen” status comes from its fixed-dose combination format: multiple active antiretroviral drugs are included in one tablet, so patients do not need to take those components as separate pills for the regimen.

How to confirm it’s the same regimen for your prescription

Whether a patient’s plan is truly “single-tablet regimen” depends on the exact prescribed regimen. Symtuza itself is a single tablet, but some treatment plans may add other antiretrovirals (or adjustments) based on prior therapy, resistance, pregnancy status, kidney/liver function, or drug interactions. The key point is that Symtuza is designed as a one-tablet regimen component for HIV therapy.